Bottom line
What is CBVZX's expense ratio?
CBVZX's expense ratio is 0.7%, or about $70 a year on every $10,000 invested. That is cheaper than 69% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load.
Updated May 22, 2026
CBVZX fee table
| Net expense ratio | 0.7% |
|---|---|
| Gross expense ratio | 0.71% |
| Management fee | 0.06% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.21% |
| Acquired fund fees | 0.44% |
| Fee waiver / reimbursement | -0.01% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed May 22, 2026
What CBVZX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CBVZX | $72 | $226 | $394 | $882 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.7% expense ratio costs roughly $39,800 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).